Committee for the Protection of Human Subjects

The Committee for the Protection of Human Subjects (CPHS) serves as the University of Oregon's Institutional Review Board (IRB). An IRB is an independent committee required under federal regulations to review and approve or disapprove, as well as monitor, research involving human participants. The mission of the CPHS/IRB is to protect the rights and welfare of par in University of Oregon research.


Submissions eligible for the Exempt or Expedited review process are reviewed on an ongoing basis throughout the year.

IRB Meeting Dates for Full Board Review
Note: The meeting dates below only apply to submissions requiring review by the fully convened IRB.


Meeting Date - Fall 2020
September 2, 2020
September 16, 2020
October 7, 2020
October 21, 2020
November 18, 2020
December 2, 2020
December 16, 2020
Meeting Date - Winter 2021
January 6, 2021
January 20, 2021
February 3, 2021
February 17, 2021
March 3, 2021
March 17, 2021
Meeting Date - Spring 2021
April 7, 2021
April 21, 2021
May 5, 2021
May 19, 2021
June 2, 2021
June 16, 2021
Meeting Date - Summer 2021
July 7, 2021
July 21, 2021
August 4, 2021
August 18, 2021

Meetings start at 8:30a.m. and are held remotely for the time being due to COVID-19. When in person meeting resume they are held at 677 East 12th Ave, Suite 500 in the main conference room (Mt. Hood - Room 506). 

Protocols may be submitted at any time. Once a protocol is determined to require full board review and is ready for consideration by the fully convened IRB, the protocol is assigned to the next available committee meeting agenda.  

NOTE: Meetings will be canceled if there are no protocol submissions.


Committee Meeting Attendance

Frequently, the committee will request a representative of the research team attend the meeting in order to explain and/or clarify portions of the proposed research. In such instances, a Research Compliance Services (RCS) staff member will contact the investigator with the anticipated time the protocol will be considered.

The investigator in attendance should be prepared to provide a brief 2-3 minute overview of the proposed research focusing on the procedures involving human subjects, the risks, and the measures in place to mitigate the risks. The floor will then be opened up to members of the board to ask any immediate questions. Afterwards, the investigator will be excused for the final deliberation and vote. An RCS Staff member will contact the investigator by the end of the week to convey the meeting outcome.

 

If you have questions, please contact Research Compliance Services.